Compare OPK & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | IART |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 1.1B |
| IPO Year | 2011 | 1996 |
| Metric | OPK | IART |
|---|---|---|
| Price | $1.10 | $14.11 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 7 |
| Target Price | $1.60 | ★ $14.33 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | $4.24 | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $8.70 |
| 52 Week High | $1.60 | $16.42 |
| Indicator | OPK | IART |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 66.47 |
| Support Level | $0.98 | $12.64 |
| Resistance Level | $1.25 | $14.38 |
| Average True Range (ATR) | 0.04 | 0.85 |
| MACD | -0.00 | 0.24 |
| Stochastic Oscillator | 52.69 | 79.73 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.